Please login to the form below

Not currently logged in
Email:
Password:

MSL Group media exec joins GCI

Becky Lauer, senior vice president and director of broadcast media/global health at MSL Group, has joined GCI Health to serve as senior vice president, director of media

Becky Lauer, who spent the past 11 years at MSL Group as senior vice president and director of broadcast media/global health, has joined GCI Health to serve as senior vice president, director of media.

In her new role, she will be responsible for providing strategic counsel and support across all GCI Health's account teams; planning and assessing media strategies; and creating media angles to reach specific target audiences.

During her time at MSL Group, Lauer provided strategic media counsel and generated media placements for healthcare clients including Pfizer, Roche, Merck, Eli Lilly, Abbott, Bayer, Novartis, sanofi-aventis, Johnson & Johnson, Daiichi-Sankyo and Genentech.

She was responsible for media relations for all FDA hearings/approvals and crisis management for MSL's healthcare practice.

Before moving to the agency side and joining MSL, Lauer spent two decades as a producer in the US for CNN, Fox News and CBS Evening News with Dan Rather.

Lauer's move comes a week after MSLGroup hired Ogilvy's David Bashaw to serve as senior vice president, deputy healthcare practice director, MSL New York.

New York City-based GCI Health is WPP's only healthcare public relations company. It was formed in 2008 when WPP merged Cohn & Wolfe and GCI Group, bringing both agencies together under the C&W name and breaking out GCI Health as a separate global healthcare agency.

GCI Health serves healthcare companies such as Johnson & Johnson, Eli Lilly, Genentech and Merck in addition to hospitals, not-for-profit organisations and other institutions.

31st May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics